SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MEDX ... anybody following?
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
2240 62 0 MEDX
Emcee:  Ed Offstein Type:  Unmoderated
Introduction Market Data Compact
Calling all biotech gurus!
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2240Periphery stuff, and I wasn't a very good scientist. I made a few contributscaram(o)uche-10/3/2018
2239And working on the correct problems. Ones that were important, difficult yet soA.J. Mullen-10/3/2018
2238I was lucky, in the correct places at correct time, and collaborated two other Nscaram(o)uche-10/3/2018
2237It’s good that you know him personally. I just watched him interviewed on the PA.J. Mullen-10/1/2018
2236Hey, Ashley! Attended seminars at Cal while Jim was there, had lots of friendlyscaram(o)uche-10/1/2018
2235Thanks for noting the connection with MEDX Ric. Here's some biographical inA.J. Mullen-10/1/2018
2234Jim Allison shares the 2018 Nobel Prize in Physiology or Medicine..... https://scaram(o)uche110/1/2018
2233pbs.twimg.com Jim Allison wins Jessie Stevenson Kovalenko medal, 2018.scaram(o)uche-1/17/2018
2232In 22.06, out 5 minutes later at 24.80. :-) ASH abstracts in 28 minutes!scaram(o)uche-11/7/2013
2231PHILLIPSBURG, N.J., Nov. 7, 2013 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. nigel bates111/7/2013
2230Yeah. But, seriously, when you look back on dedication.... sales in incy comscaram(o)uche-8/25/2013
2229I would guess 10X. <<<What would the share price be today, if they harkrw-8/25/2013
2228Icebrg.... Biotech Stock-picker of the Decade. :-) What would the share pricscaram(o)uche-8/24/2013
2227>> To help mitigate these risks, the new guidance document will apply to wscaram(o)uche-6/4/2012
2226Fact is, if you recruit someone to a biotech from a big pharma -- with a tree-liscaram(o)uche-3/1/2012
2225Looks like cldx will hit its highest volume since June? Why the big run-up, andscaram(o)uche-2/3/2012
2224Celldex Therapeutics Announces Initiation of Phase 1 Clinical Trial of CDX-1127 scaram(o)uche112/19/2011
2223High five, Jim Allison.scaram(o)uche-3/21/2011
2222finance.yahoo.com Phase III Study of Investigational Compound Ipilimumab Achievscaram(o)uche-3/21/2011
2221Investigational Compound Ipilimumab Demonstrates Improved Overall Survival in Phscaram(o)uche-6/5/2010
2220last paper I could find where he was either first or senior author..... Nature.scaram(o)uche-3/6/2010
2219PB: I think that you know this, but I did work with methylcholantrene-induced sscaram(o)uche-3/6/2010
2218Not sure if what you are saying would or would not be in conflict with SchreiberPseudo Biologist-3/6/2010
2217pharmastrategyblog.com Now THAT is what a tumor immunologist expects, not some scaram(o)uche-3/6/2010
2216PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces retnsaf-3/1/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News